Aerpio Pharmaceuticals Inc. (NASDAQ: ARPO) open the trading on May 18, 2021, with great promise as it jumped 18.67% to $1.97. During the day, the stock rose to $1.99 and sunk to $1.54 before settling in for the price of $1.66 at the close. Taking a more long-term approach, ARPO posted a 52-week range of $0.70-$2.31.
Meanwhile, its Annual Earning per share during the time was 30.90%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 82.30%. This publicly-traded company’s shares outstanding now amounts to $47.17 million, simultaneously with a float of $45.16 million. The organization now has a market capitalization sitting at $85.93 million. At the time of writing, stock’s 50-day Moving Average stood at $1.3320, while the 200-day Moving Average is $1.4264.
If we measure the efficiency of the company that is accounted for 12 employees. It has generated 1,250,000 per worker during the last fiscal year. For the Profitability, stocks operating margin was -42.38 and Pretax Margin of -28.77.
Aerpio Pharmaceuticals Inc. (ARPO) Ownership Facts and Figures
Sometimes it helps to make our mind if we keep our tabs on how bigger investors are working with the stock of the Biotechnology industry. Aerpio Pharmaceuticals Inc.’s current insider ownership accounts for 0.70%, in contrast to 47.50% institutional ownership. According to the most recent insider trade that took place on Dec 08, this organization’s 10% Owner sold 21,400 shares at the rate of 1.96, making the entire transaction reach 41,944 in total value, affecting insider ownership by 0.
Aerpio Pharmaceuticals Inc. (ARPO) Earnings and Revenue Records
So, what does the last quarter earnings report of the company that was made public on 3/31/2021 suggests? It has posted -$0.09 earnings per share (EPS) beating the forecaster’s viewpoint (set at -$0.09) by $0. This company achieved a net margin of -28.77 while generating a return on equity of -10.84. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.06 per share during the current fiscal year.
Aerpio Pharmaceuticals Inc.’s EPS increase for this current 12-month fiscal period is 82.30% and is forecasted to reach -0.39 in the upcoming year.
Aerpio Pharmaceuticals Inc. (NASDAQ: ARPO) Trading Performance Indicators
Let’s observe the current performance indicators for Aerpio Pharmaceuticals Inc. (ARPO). It’s Quick Ratio in the last reported quarter now stands at 24.00. The Stock has managed to achieve an average true range (ATR) of 0.15. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 5.73.
In the same vein, ARPO’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.09, a figure that is expected to reach -0.10 in the next quarter, and analysts are predicting that it will be -0.39 at the market close of one year from today.
Technical Analysis of Aerpio Pharmaceuticals Inc. (ARPO)
[Aerpio Pharmaceuticals Inc., ARPO] recent stats showed that its last 5-days Average volume was superior the volume it posted in the year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 85.48% While, its Average True Range was 0.1938.
Raw Stochastic average of Aerpio Pharmaceuticals Inc. (ARPO) in the period of the previous 100 days is set at 84.95%, which indicates a major fall in contrast to 98.07% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 173.46% that was higher than 97.65% volatility it exhibited in the past 100-days period.